ArticleMolecular cancer therapeutics2022

BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors.

Michael Rigby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.